Epicentre, Paris, France.
Médecins Sans Frontières, Paris, France.
Int J Tuberc Lung Dis. 2014 Feb;18(2):160-7. doi: 10.5588/ijtld.13.0369.
Armenia, a country with a high prevalence of drug-resistant tuberculosis (DR-TB).
To identify factors related to default from DR-TB treatment in Yerevan.
Using a retrospective cohort design, we compared defaulters with patients who were cured, completed or failed treatment. Patients who initiated DR-TB treatment from 2005 to 2011 were included in the study. A qualitative survey was conducted including semi-structured interviews with defaulters and focus group discussions with care providers.
Of 381 patients, 193 had achieved treatment success, 24 had died, 51 had failed treatment and 97 had defaulted. The number of drugs to which the patient was resistant at admission (aRR 1.16, 95%CI 1.05-1.27), the rate of treatment interruption based on patient's decision (aRR 1.03, 95%CI 1.02-1.05), the rate of side effects (aRR 1.18, 95%CI 1.09-1.27), and absence of culture conversion during the intensive phase (aRR 0.47, 95%CI 0.31-0.71) were independently associated with default from treatment. In the qualitative study, poor treatment tolerance, a perception that treatment was inefficient, lack of information, incorrect perception of being cured, working factors and behavioural problems were factors related to treatment default.
In addition to economic reasons, poor tolerance of and poor response to treatment were the main factors associated with treatment default.
亚美尼亚是一个耐药结核病(DR-TB)高发的国家。
确定埃里温地区耐多药结核病(DR-TB)患者治疗中断的相关因素。
采用回顾性队列设计,我们比较了失访患者与治愈、完成或治疗失败的患者。纳入了 2005 年至 2011 年期间开始 DR-TB 治疗的患者。进行了一项定性调查,包括对失访者进行半结构访谈和对护理提供者进行焦点小组讨论。
381 名患者中,193 名患者获得了治疗成功,24 名患者死亡,51 名患者治疗失败,97 名患者失访。入院时患者耐药的药物种类(aRR 1.16,95%CI 1.05-1.27)、基于患者决定的治疗中断率(aRR 1.03,95%CI 1.02-1.05)、副作用发生率(aRR 1.18,95%CI 1.09-1.27)和强化期培养未转化(aRR 0.47,95%CI 0.31-0.71)与治疗中断独立相关。在定性研究中,较差的治疗耐受性、治疗效果不佳的认知、缺乏信息、对治愈的错误认知、工作因素和行为问题是与治疗中断相关的因素。
除经济原因外,对治疗的耐受性差和治疗反应不佳是与治疗中断相关的主要因素。